These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19923181)

  • 1. Characterization of T-cell responses in macaques immunized with a single dose of HIV DNA vaccine.
    Arrode-Brusés G; Sheffer D; Hegde R; Dhillon S; Liu Z; Villinger F; Narayan O; Chebloune Y
    J Virol; 2010 Feb; 84(3):1243-53. PubMed ID: 19923181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term central and effector SHIV-specific memory T cell responses elicited after a single immunization with a novel lentivector DNA vaccine.
    Arrode-Brusés G; Moussa M; Baccard-Longere M; Villinger F; Chebloune Y
    PLoS One; 2014; 9(10):e110883. PubMed ID: 25337803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of a lentiviral-based DNA vaccine driven by the 5'LTR of the naturally attenuated caprine arthritis encephalitis virus (CAEV) in mice and macaques.
    Arrode-Brusés G; Hegde R; Jin Y; Liu Z; Narayan O; Chebloune Y
    Vaccine; 2012 Apr; 30(19):2956-62. PubMed ID: 22387218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques.
    Luckay A; Sidhu MK; Kjeken R; Megati S; Chong SY; Roopchand V; Garcia-Hand D; Abdullah R; Braun R; Montefiori DC; Rosati M; Felber BK; Pavlakis GN; Mathiesen I; Israel ZR; Eldridge JH; Egan MA
    J Virol; 2007 May; 81(10):5257-69. PubMed ID: 17329330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene.
    Casimiro DR; Tang A; Perry HC; Long RS; Chen M; Heidecker GJ; Davies ME; Freed DC; Persaud NV; Dubey S; Smith JG; Havlir D; Richman D; Chastain MA; Simon AJ; Fu TM; Emini EA; Shiver JW
    J Virol; 2002 Jan; 76(1):185-94. PubMed ID: 11739684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
    Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
    Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
    García-Arriaza J; Perdiguero B; Heeney JL; Seaman MS; Montefiori DC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Self SG; Borate B; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Lee C; Kibler KV; Jacobs BL; Wagner R; Ding S; Pantaleo G; Esteban M
    J Virol; 2017 May; 91(9):. PubMed ID: 28179536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel non-integrative single-cycle chimeric HIV lentivector DNA vaccine.
    Moussa M; Arrode-Brusés G; Manoylov I; Malogolovkin A; Mompelat D; Ishimwe H; Smaoune A; Ouzrout B; Gagnon J; Chebloune Y
    Vaccine; 2015 May; 33(19):2273-2282. PubMed ID: 25825333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF.
    Barouch DH; Santra S; Tenner-Racz K; Racz P; Kuroda MJ; Schmitz JE; Jackson SS; Lifton MA; Freed DC; Perry HC; Davies ME; Shiver JW; Letvin NL
    J Immunol; 2002 Jan; 168(2):562-8. PubMed ID: 11777947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses.
    Koup RA; Roederer M; Lamoreaux L; Fischer J; Novik L; Nason MC; Larkin BD; Enama ME; Ledgerwood JE; Bailer RT; Mascola JR; Nabel GJ; Graham BS; ;
    PLoS One; 2010 Feb; 5(2):e9015. PubMed ID: 20126394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained peptide-specific gamma interferon T-cell response in rhesus macaques immunized with human immunodeficiency virus gag DNA vaccines.
    Caulfield MJ; Wang S; Smith JG; Tobery TW; Liu X; Davies ME; Casimiro DR; Fu TM; Simon A; Evans RK; Emini EA; Shiver J
    J Virol; 2002 Oct; 76(19):10038-43. PubMed ID: 12208982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost.
    Hulot SL; Korber B; Giorgi EE; Vandergrift N; Saunders KO; Balachandran H; Mach LV; Lifton MA; Pantaleo G; Tartaglia J; Phogat S; Jacobs B; Kibler K; Perdiguero B; Gomez CE; Esteban M; Rosati M; Felber BK; Pavlakis GN; Parks R; Lloyd K; Sutherland L; Scearce R; Letvin NL; Seaman MS; Alam SM; Montefiori D; Liao HX; Haynes BF; Santra S
    J Virol; 2015 Jun; 89(12):6462-80. PubMed ID: 25855741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses.
    Santana VC; Almeida RR; Ribeiro SP; Ferreira LC; Kalil J; Rosa DS; Cunha-Neto E
    Mem Inst Oswaldo Cruz; 2015 Dec; 110(8):1010-6. PubMed ID: 26602876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates.
    Ribeiro SP; De Moura Mattaraia VG; Almeida RR; Valentine EJG; Sales NS; Ferreira LCS; Sa-Rocha LC; Jacintho LC; Santana VC; Sidney J; Sette A; Rosa DS; Kalil J; Cunha-Neto E
    Vaccine; 2022 Jan; 40(2):239-246. PubMed ID: 34961636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines.
    zur Megede J; Otten GR; Doe B; Liu H; Leung L; Ulmer JB; Donnelly JJ; Barnett SW
    J Virol; 2003 Jun; 77(11):6197-207. PubMed ID: 12743276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant rubella vectors elicit SIV Gag-specific T cell responses with cytotoxic potential in rhesus macaques.
    Rosati M; Alicea C; Kulkarni V; Virnik K; Hockenbury M; Sardesai NY; Pavlakis GN; Valentin A; Berkower I; Felber BK
    Vaccine; 2015 Apr; 33(18):2167-74. PubMed ID: 25802183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of HIV-1 IIIB and SHIV 89.6P Tat and Tat toxoids in rhesus macaques: induction of humoral and cellular immune responses.
    Richardson MW; Mirchandani J; Silvera P; Régulier EG; Capini C; Bojczuk PM; Hu J; Gracely EJ; Boyer JD; Khalili K; Zagury JF; Lewis MG; Rappaport J
    DNA Cell Biol; 2002 Sep; 21(9):637-51. PubMed ID: 12396606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
    Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
    AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Approaches for Increasing the Immunogenicity of an Epitope-Based Anti-HIV Vaccine.
    Rosa DS; Ribeiro SP; Fonseca SG; Almeida RR; Santana VC; Apostólico Jde S; Kalil J; Cunha-Neto E
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1077-88. PubMed ID: 26149745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239.
    Horton H; Vogel TU; Carter DK; Vielhuber K; Fuller DH; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Montefiori DC; Erfle V; Desrosiers RC; Wilson N; Picker LJ; Wolinsky SM; Wang C; Allison DB; Watkins DI
    J Virol; 2002 Jul; 76(14):7187-202. PubMed ID: 12072518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.